New Cells, New Vaccines VI: Target to Market

An international conference organized by the International Alliance for Biological Standardization and the Fraunhofer USA Center for Molecular Biotechnology.

New Cells, New Vaccines VI, the latest conference in a series that began in 2005, will be of interest to scientists in the biotechnology and pharmaceutical industries involved in vaccine development and production, as well as academics, regulatory and public health authorities, and medical and veterinary experts. The venue and the meeting provide a perfect opportunity to interact with colleagues from industry, academia and regulatory agencies to exchange views and ideas and explore potential collaboration.

Please visite the conference website, www.ncnv.org to review planned conference sessions and for registration information.

Alternative Methods for Human and Veterinary Rabies Vaccine Potency Testing: State of the Science and Planning the Way Forward

An international Workshop organized by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), with the support of IABS.

Reference Standards for Therapeutic Proteins: Their Relevance, Development, Qualification and Replacement

Co-sponsored by the Center for Drugs Evaluation and Research/Food abd Drug Administration (CDER/FDA), National Institute of Standards and Technology, National Institute for Allergy and Infectious Diseases NIAID and the International Alliance for Biological Standardization (IABS). 2

Reference Standards Program Summary

Scientific Program including Slides

Adventitious Agents, New Technology, and Risk Assessment

IABS meeting and satellite event to the 14th Annual Conference on Vaccine Research, organized by the National Foundation for Infectious Diseases.

SCIENTIFIC PROGRAMME including Slides and Abstracts